Nearly all those who have Medicare Advantage plans must deal with prior authorization. Now more prior authorization issues are appearing with Part D prescription drugs.

CTSO READ THE FULL CTSO RESEARCH REPORT Regulatory Update on DrugSorb-ATR On April 25, 2025, the FDA issued a denial letter regarding CytoSorbents’ (NASDAQ:CTSO) De Novo Request for DrugSorb-ATR ...

We live in a complicated world and try to find ways to simplify it. During this past legislative session, key legislation ...

Jurisdiction: Supreme Court of New York, Appellate Division, First Department - The Supreme Court of New York, New York County, on March 13, ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

Rep. Dr. Greg Murphy (R-N.C.) hopes his personal ordeal with prior authorizations will help inspire Congress to act.